Online citations, reference lists, and bibliographies.
← Back to Search

Importance Of Combined Assessment Of Skeletal Muscle Mass And Density By Computed Tomography In Predicting Clinical Outcomes After Transcatheter Aortic Valve Replacement

T. Tokuda, M. Yamamoto, A. Kagase, Yutaka Koyama, T. Otsuka, Norio Tada, Toru Naganuma, M. Araki, F. Yamanaka, S. Shirai, Kazuki Mizutani, M. Tabata, Hiroshi Ueno, K. Takagi, Akihiro Higashimori, Y. Watanabe, Kentaro Hayashida, the OCEAN-TAVI investigators
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Skeletal muscle mass (SMM) as calculated by computed tomography (CT) is a predictor of all-cause mortality after transcatheter aortic valve replacement (TAVR), but it remains unclear whether using CT-determined density of skeletal muscle has additive prognostic value. We utilized the Japanese multicenter registry data of 1375 patients who underwent CT prior to TAVR. Sarcopenia status was defined by the CT-derived SMM index (threshold: men, 55.4 cm 2 /m 2 ; women, 38.9 cm 2 /m 2 ). The threshold for high and low CT density was based on the median value of the entire cohort (men: 33.4 HU; women: 29.5 HU). Sarcopenia was observed in 802 patients (58.3%) overall. Patients were categorized into non-sarcopenia and high-CT density (n = 298), non-sarcopenia and low-CT density (n = 275), sarcopenia and high-CT density (n = 399), and sarcopenia and low-CT density (n = 403) groups, and procedural outcomes and mortality compared. The cumulative 3-year mortality rates in these groups were 18%, 27%, 24%, and 32%, respectively. Cox-regression multivariate analysis revealed that low-CT density (compared with high-CT density) and sarcopenia and low-CT density (compared with non-sarcopenia and high-CT density as reference) increased mortality after TAVR (hazard ratios [HR]: 1.35 and 1.43, 95% confidence intervals [Cis]: 1.06–1.72 and 1.00–2.08, p = 0.01, and 0.049, respectively). However, sarcopenia alone was not related to an increased risk of mortality (HR 1.30, 95% CI 0.99–1.69, p = 0.52). In conclusion, CT density-based skeletal muscle quality assessment combined with the SMM index improves prediction of adverse outcomes after TAVR.
This paper references
Prognostic Value of Psoas Muscle Area and Density in Patients Who Undergo Cardiovascular Surgery.
M. Yamashita (2017)
Prognostic Value of Fat Mass and Skeletal Muscle Mass Determined by Computed Tomography in Patients Who Underwent Transcatheter Aortic Valve Implantation.
M. Mok (2016)
Effect of sarcopenia on clinical and surgical outcome in elderly patients with proximal femur fractures
Ching-Di Chang (2017)
Low radiographic muscle density is associated with lower overall and disease-free survival in early-stage colorectal cancer patients
H. van Baar (2018)
Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort.
A. Newman (2006)
Psoas Muscle Area as a Predictor of Outcomes in Transcatheter Aortic Valve Implantation.
L. Garg (2017)
Sarcopenia is a risk factor for complications and an independent predictor of hospital length of stay in trauma patients.
James DeAndrade (2018)
Prognostic Value of Hypoalbuminemia After Transcatheter Aortic Valve Implantation (from the Japanese Multicenter OCEAN-TAVI Registry).
M. Yamamoto (2017)
Usefulness of Psoas Muscle Area to Predict Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement.
M. Saji (2016)
Usefulness of Psoas Muscle Area and Volume and Frailty Scoring to Predict Outcomes After Transcatheter Aortic Valve Implantation.
Pawel Kleczynski (2018)
Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
Vishal Dahya (2016)
Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study.
B. Goodpaster (2001)
Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement
Tetsuro Shimura (2017)
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.
M. León (2016)
Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content.
B. Goodpaster (2000)
Gait Speed Can Predict Advanced Clinical Outcomes in Patients Who Undergo Transcatheter Aortic Valve Replacement: Insights From a Japanese Multicenter Registry
S. Kano (2017)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
A. Kappetein (2012)
Opportunistic Measurement of Skeletal Muscle Size and Muscle Attenuation on Computed Tomography Predicts 1-Year Mortality in Medicare Patients.
L. Lenchik (2019)
Psoas Muscle Area and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The Montreal-Munich Study.
Samuel Mamane (2016)
Sarcopenia: Current Concepts and Imaging Implications.
R. Boutin (2015)
The Health ABC Study
BH Goodpaster (1985)
Influence of body composition profile on outcomes following colorectal cancer surgery
G. Malietzis (2016)
Transcatheter versus surgical aortic-valve replacement in high-risk patients.
C. Smith (2011)
Low Skeletal Muscle Density Is Associated with Early Death in Patients with Perihilar Cholangiocarcinoma Regardless of Subsequent Treatment
J. L. V. van Vugt (2018)
Frailty in older adults: evidence for a phenotype.
L. Fried (2001)
Computed tomography-based fat and muscle characteristics are associated with mortality after transcatheter aortic valve replacement.
B. Foldyna (2018)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar